Test Before Treat: Biomarker Testing for Chronic Lymphocytic Leukemia (CLL)
Test Before Treat is one of the most important things you can do for your CLL / SLL. Obtaining the appropriate biomarker tests at the right time will guide treatment decisions and help predict how aggressively the disease might behave in the future. The resources below will teach you what the three most vital biomarker tests are so you can advocate for your best care.
Action Items for Test Before Treat™
Work your way through videos and interactive quizzes that will expand your knowledge.
Learn about biomarker testing in CLL and how it can help guide your treatment decisions. Share this handout with your healthcare provider.
Before starting your first treatment, and prior to every subsequent treatment, know which tests you absolutely must have, which we strongly advise through CLL Society’s Test Before Treat™ campaign. Two patients share their stories about the importance of getting the right tests completed prior to choosing which treatment will be best for them. Click here.
Have you been concerned that you might not be receiving the best treatment for your CLL or SLL? Apply today for a free, HIPAA-compliant, expert second opinion consult through CLL Society’s Expert Access™ program.
Read it. Print it out. Share it with your treating physician. Click here.
From point A to Z, CLL Society will share which tests you should be advocating for to ensure you are receiving the best possible care.
Join CLL Society for this important Ed Forum to learn the basics about testing across the span of your CLL journey. At the time of diagnosis, find out which tests should be performed, which might be avoided, and why.
Before starting your first treatment, and prior to every subsequent treatment, know which tests you absolutely must have, which we strongly advise through CLL Society’s Test Before Treat™ campaign. Two patients will share their stories about the importance of getting the right tests completed prior to choosing treatment. Finally, learn how CLL is monitored over time, and how the evolving role of MRD (measurable residual disease) testing may help determine when to stop therapy in CLL. Click here.
Awake worrying that you are receiving the wrong treatment for your CLL? Stop worrying and take action. Apply today for a free, HIPPA-compliant Expert 2nd Opinion consult through CLL Society’s Expert Access™ program. Click here.
PROGRAM FEATURES
What Doctors Say About Test Before Treat™
What critical concern could compel these CLL experts from some of the top research centers around the world to come before our cameras and speak so urgently to you, our readers? The answer: Test Before Treat™! The truth is that critical tests which can predict which patients will do well or fail on certain medications and which should be done before each and every treatment decision, are often not being done… or are being done and the results are ignored. Take our patients’ stories to heart. Print out our one-pager. Share it with your doctor. Smart Patients Get Smart Care™. Read more.
Test Before Treat™ Patient Stories
Whatever the stage of your journey with CLL, chances are good that your fellow CLL Society readers have walked or are walking that very road. Through the generous sharing of their stories we can gain strength, courage and information.
Please read and act at all times as your own best advocate.
Smart Patients Get Smart Care™. Read More.
This program is made possible in part by grant support from Genentech, Janssen Oncology, and Pharmacyclics.
ADDITIONAL READING
